69 filings
Page 2 of 4
6-K
yiul79dfp47ekc9fyd3b
23 Mar 12
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2011 Results
12:00am
6-K
7968vke1x41aml4mhmhc
23 Nov 11
3SBio Inc. Announces Unaudited Third Quarter 2011 Results
12:00am
6-K
od0 fvhi03g2afrosg
20 Oct 11
3SBIO Inc. Announces Results of 2011 Annual General Meeting
12:00am
6-K
f2rd mzyxxyw
7 Sep 11
Current report (foreign)
12:00am
6-K
o4tby2uj
7 Sep 11
Current report (foreign)
12:00am
6-K
wpg83wza
21 Jul 11
3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
12:00am
6-K
4euc9yq3
19 May 11
3SBio Inc. Announces Unaudited First Quarter 2011 Results
12:00am
6-K
w8yn ce8xdmdbu
25 Mar 11
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2010 Results
12:00am
6-K
wjfv8 em6cd8vt23w86
28 Jan 11
Current report (foreign)
12:00am
6-K
w600h
10 Dec 10
3SBIO Inc. Announces Results of Annual General Meeting
12:00am
6-K
a0q 5xu0f3eni
22 Nov 10
3SBio Inc. Announces Unaudited Third Quarter Results
12:00am
6-K
ktye9858nbwt2nbt
12 Oct 10
Current report (foreign)
12:00am
6-K
dm87lav4edbl 3vb4f8
7 Sep 10
3SBio and Isotechnika Pharma Announce Strategic Partnership
12:00am
6-K
tp2qp9618
25 Aug 10
Current report (foreign)
12:00am
6-K
tzegrpb5p6 xp
24 May 10
Current report (foreign)
12:00am
6-K
fnaw ae1e
23 Mar 10
3SBio Announces Changes to its Board of Directors
12:00am
6-K
bsfnbvy5vmxevh8j
23 Feb 10
Current report (foreign)
12:00am
6-K
3lvgx bjs
23 Feb 10
Current report (foreign)
12:00am
6-K
rooj9ps
23 Feb 10
3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
12:00am
6-K
d1c56
11 Feb 10
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxilfor Hyperphosphatemia
12:00am